Yi Honggang

ViceDirector of  Department of  Biostatistics, Nanjing Medical University

Associate Professor of  Biostatistics

honggangyi@njmu.edu.cn

易洪刚,　博士副教授

Honggang Yi, MD, PhD

Research Interest

Statistical Methods inepidemiology

Statistical Theories and Methods for Clinical Trials 

Education

Nantong Medical College, Preventive Medicine, B.S. (1996.9-2001.7)

Nantong Medical College, Epidemiology and Biostatistics, M.S. (2001.9-2004.7)

Nanjing Medical University, Epidemiology and Biostatistics, Ph.D.(2007.9-2014.7)

University of  Nevada, Reno, School of Community Health Sciences, USA,Visitingscholar (2009.12-2010.6)

The Ohio State University, School of Medicine,USA,Post-doctoralScientist (2016.3-2017.8)

Honors and Awards:

2021 Instructor of  the gold award of the 10th medical technology skills competition on publichealth track of Chinese College Students

2018 YangZiJiang Special Award 'for Nanjing Medical University's Teachers

Publications

Books

1. Statistical Genetics: Gene Mapping Through Linkage and Association. People'sMedical Publishing House. 2017.

2. Hygiene(Ebook).People's Military Medical Press. 2016.

3. Medical Statistics.3nd, Beijing: China Statistics Press. 2016.

4. Learning Guidanceand Exercises of Medical Statistics. People's Medical PublishingHouse. 2016.

5. Statistical Interpretation for Selected Cases of Clinical Trials. People'sMedical Publishing House. 2015.

6. Theory and Practiceof Public Health in China. People's Medical Publishing House. 2015.

7. Medical Statistics.3nd, Beijing: China Statistics Press. 2014.

8. Preventive Medicine, Medical Statistics and Epidemiology. Zhejiang UniversityPress. 2014.

9. Fundamentals of Biostatistics. People's Medical Publishing House. 2010.

10. Medical Statistics Method. 3nd, Fudan University Press. 2009.

11. Medical Statistics.2nd, Beijing: China Statistics Press. 2007.

Selected Papers

1. Tang Y^*,You D^*,Yi H^*,Yang S, Zhao Y. IPRS: Leveraging Gene-Environment Interaction toReconstruct Polygenic Risk Score. Front Genet. 2022 Mar24;13:801397. doi: 10.3389/fgene.2022.801397. PMID: 35401709; PMCID:PMC8989431.(IF=4.77)

2. ShiN^*,Liu B^*,Liang N^*,Ma Y^*,Ge Y^*,Yi H^*,Wo H, Gu H, Kuang Y, Tang S, Zhao Y, Tong L, Liu S, Zhao C, Chen R,Bai W, Fan Y, Shi Z, Li L, Liu J, Gu H, Zhi Y, Wang Z, Li Y, Li H,Wang J, Jiao L, Tian Y, Xiong Y, Huo R, Zhang X, Bai J, Chen H, ChenL, Feng Q, Guo T, Hou Y, Hu G, Hu X, Hu Y, Huang J, Huang Q, HuangS, Ji L, Jin H, Lei X, Li C, Wu G, Li J, Li M, Li Q, Li X, Liu H,Liu J, Liu Z, Ma Y, Mao Y, Mo L, Na H, Wang J, Song F, Sun S, WangD, Wang M, Wang X, Wang Y, Wang Y, Wu W, Wu L, Xiao Y, Xie H, Xu H,Xu S, Xue R, Yang C, Yang K, Yang P, Yuan S, Zhang G, Zhang J, ZhangL, Zhao S, Zhao W, Zheng K, Zhou Y, Zhu J, Zhu T, Li G, Wang W,Zhang H, Wang Y, Wang Y. Association between early treatment withQingfei Paidu decoction and favorable clinical outcomes in patientswith COVID-19: A retrospective multicenter cohort study. PharmacolRes.2020 Nov;161:105290. doi: 10.1016/j.phrs.2020.105290. Epub 2020 Nov9. PMID: 33181320; PMCID: PMC7833425. (IF=10.33)

3. Yi H,Corrigan JD, Singichetti B, Bogner JA, Manchester K, Guo J, Yang J.Lifetime History of Traumatic Brain Injury and Current DisabilityAmong Ohio Adults. J Head Trauma Rehabil. 2018Jul/Aug;33(4):E24-E32. doi: 10.1097/HTR.0000000000000352. PMID:29084102.(IF=3.17)

4. Wo H, HeJ, Zhao Y, Yu H, Chen F, Yi H.The Efficacy and Toxicity of Gefitinib in Treating Non-small CellLung Cancer: A Meta-analysis of 19 Randomized Clinical Trials. JCancer. 2018 Apr 6;9(8):1455-1465. doi: 10.7150/jca.23356. PMID:29721056; PMCID: PMC5929091.(IF=4.47)

5. Yi H,Wo H, Zhao Y, Zhang R, Dai J, Jin G, Ma H, Wu T, Hu Z, Lin D, ShenH, Chen F. Comparison of dimension reduction-based logisticregression models for case-control genome-wide association study:principal components analysis vs. partial least squares. J BiomedRes. 2015 Jul;29(4):298-307. doi: 10.7555/JBR.29.20140043. Epub 2015Apr 20. PMID: 26243516; PMCID: PMC4547378.